NCT01250561

Reduction of Postherpetic Neuralgia in Herpes Zoster

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 133 (actual)
• Sponsor: Center for Clinical Studies, Texas · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.

Conditions

• Herpes Zoster
• Post-herpetic Neuralgia

Interventions

Type	Name	Description
DRUG	Gabapentin	gabapentin 300mg/day, titrated up weekly to max tolerated dose or 3600mg/day (whichever is lower), for 4-9 weeks
DRUG	Valacyclovir	valacyclovir 1000mg three-times daily x 7 days

Timeline

• Start date: 2002-02-01
• Primary completion: 2007-10-01
• Completion: 2007-10-01
• First posted: 2010-12-01
• Last updated: 2010-12-01

Locations

1 site across 1 country: United States